Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Mustang Bio’s AML Treatment Receives Orphan Drug Designation

contractpharmaJuly 31, 2019

Tag: Mustang , Orphan , MB-102 , AML

PharmaSources Customer Service